<DOC>
	<DOCNO>NCT00894283</DOCNO>
	<brief_summary>This pilot study design determine feasibility conduct randomized clinical trial compare fondaparinux sodium ( Arixtra ) daily enoxaparin ( LovenoxÂ® ) twice daily respect prevent deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) bariatric surgery obese patient .</brief_summary>
	<brief_title>A Pilot Study Comparing Enoxaparin Fondaparinux Prevent Venous Thromboembolism ( VTE ) Bariatric Surgical Patients</brief_title>
	<detailed_description>In order determine feasibility trial need determine necessary sample size . In order determine necessary sample size , need obtain estimate incidence DVT prevalence PE use MRV treatment group . Descriptive statistic 95 % confidence interval calculate determine incidence DVT prevalence PE use MRV obese patient receive treatment prevent DVT PE associate bariatric surgery . Anti-factor Xa level use help determine treatment reach appropriate level .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>1 . Men woman 18 year old . 2 . Body mass index ( BMI ) 35kg/m2 great . 3 . Undergoing laparoscopic bariatric surgery , i.e. , laparoscopic sleeve gastrectomy , laparoscopic Rouxen Y gastric bypass laparoscopic duodenal switch . 1 . History previous deep vein thrombosis . 2 . History previous pulmonary embolus . 3 . History documented clotting/coagulation disorder . 4 . History cancer . 5 . Weight &lt; 50 kg &gt; 200 kg unable fit MRI scanner . 6 . Presence metallic foreign body 7 . Recent history smoking ( within last year ) . 8 . History venous stasis disease . 9 . History obesity hypoventilation syndrome . 10 . Patients unable lay flat extend period time claustrophobic . 11 . Patients pacemaker , implant defibrillator certain implanted electronic metallic device ( implanted medical metallic device , shrapnel , metal ) . 12 . History hypersensitivity reaction anticoagulation product . 13 . History HIT ( Heparin Induced Thrombocytopenia . 14 . History Renal Insufficiency ( Creatinine Clearance &lt; 50 ) . 15 . Active clinically significant bleeding . 16 . Acute bacterial endocarditis . 17 . BMI &gt; 60 . 18 . Patients metallic foreign body implant ( unable MRV study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>DVT</keyword>
	<keyword>PE</keyword>
	<keyword>MRV</keyword>
	<keyword>bariatric surgery</keyword>
</DOC>